MedElevator Войти в исследования
← Поиск публикаций

DOI 10.24875/recice.m25000544

Медицинская библиотека · REC, interventional cardiology · 2025

VerifyNow in acute coronary syndrome: design of the EPIC17-VERONICA trial to optimize platelet inhibition.

Garilleti Cámara Celia, de la Torre-Hernández José María, Rumoroso Cuevas José Ramón, Romaní Sebastián, Monastyrski Andrea Virginia, Nieto Alejandro Diego, Bayón Lorenzo Jeremías, Cubero Gallego Héctor, Gómez-Hospital Joan Antoni, Vallejo Calcerrada Nuria, Pérez Guerrero Ainhoa, Amat-Santos Ignacio J, Alcalde Martínez Vicente, López-Palop Ramón, Jimeno Sánchez Javier, Pérez de Prado Armando, Lozano Martínez-Luengas Íñigo

СтатьяПеревод в очереди

Аннотация

INTRODUCTION AND

OBJECTIVES

De-escalation from prasugrel and ticagrelor to clopidogrel in patients undergoing percutaneous coronary intervention after acute coronary syndrome (ACS) is a strategy aimed at reducing bleeding. This study evaluates whether VerifyNow (Werfen, Spain)-guided de-escalation, based on platelet aggregation measurement, provides a therapeutic benefit in ACS management.

METHODS

This ongoing multicenter, prospective, randomized 1:1 trial will enroll 634 patients with ACS who underwent revascularization with a sirolimus-eluting stent and were discharged on dual antiplatelet therapy with ticagrelor or prasugrel. Only those patients with a very low platelet reactivity level (platelet reactivity units ≤ 30) based on VerifyNow 1 month after discharge will be included. The primary endpoint is a composite of cardiovascular death, nonfatal acute myocardial infarction, nonfatal stroke, and bleeding at 1-year follow-up.

RESULTS

The EPIC17-VERONICA study (NCT04654052) will reveal the efficacy profile of the de-escalation strategy, based on the VerifyNow platelet aggregation test, and determine the role of this device in the selection of patients who are eligible to benefit from this strategy.

CONCLUSIONS

This study will determine whether platelet function testing provide clinical benefit in the management of patients with ACS.

Для цитирования: Garilleti Cámara Celia, de la Torre-Hernández José María, Rumoroso Cuevas José Ramón, Romaní Sebastián, Monastyrski Andrea Virginia, Nieto Alejandro Diego, Bayón Lorenzo Jeremías, Cubero Gallego Héctor, Gómez-Hospital Joan Antoni, Vallejo Calcerrada Nuria, Pérez Guerrero Ainhoa, Amat-Santos Ignacio J, Alcalde Martínez Vicente, López-Palop Ramón, Jimeno Sánchez Javier, Pérez de Prado Armando, Lozano Martínez-Luengas Íñigo. VerifyNow in acute coronary syndrome: design of the EPIC17-VERONICA trial to optimize platelet inhibition.. REC, interventional cardiology. 2025. DOI: 10.24875/recice.m25000544.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.